Literature DB >> 29805667

Prostate cancer cell proliferation is suppressed by microRNA-3160-5p via targeting of F-box and WD repeat domain containing 8.

Ping Lin1, Lijuan Zhu1, Wenjing Sun1, Zhengkai Yang1, Hui Sun1, Dong Li1, Rongjun Cui1,2, Xiulan Zheng1,3, Xiaoguang Yu1.   

Abstract

MicroRNAs (miRNAs/miRs), which are endogenous non-coding single-stranded RNAs 19-25 nucleotides in length, regulate gene expression by blocking translation or transcription repression. The present study revealed that miR-3160-5p was widely expressed in prostate cancer cells by reverse transcription-quantitative polymerase chain reaction. There was a negative association between the expression of miR-3160-5p and F-box and WD repeat domain containing 8 (Fbxw8) in prostate cancer DU145 cells. A luciferase activity assay was used to verify that Fbxw8 is the target of miR-3160-5p. In the present study, using MTT assay and cell cycle analysis, it was demonstrated that DU145 cell proliferation was repressed and the cell cycle was arrested in the G2/M cell cycle phase with upregulation of miR-3160-5p. Subsequent studies demonstrated that miR-3160-5p regulated the progression of the cell cycle in DU145 prostate cancer cells when the expression levels of phosphorylated cell division cycle (CDC)2, CDC25C and cyclin B1 were directly inhibited. Taken together, these findings revealed the mechanism underlying the role of miR-3160-5p in regulating the proliferation of DU145 cells and indicated that miR-3160-5p may serve as a promising novel therapeutic tool for prostate cancer.

Entities:  

Keywords:  F-box and WD repeat domain containing 8; cell cycle; cell proliferation; microRNA-3160-5p; prostate cancer

Year:  2018        PMID: 29805667      PMCID: PMC5958718          DOI: 10.3892/ol.2018.8505

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development.

Authors:  Ryosuke Tsunematsu; Masaaki Nishiyama; Shuhei Kotoshiba; Toru Saiga; Takumi Kamura; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 3.  Roles of microRNAs during prostatic tumorigenesis and tumor progression.

Authors:  Y-X Fang; W-Q Gao
Journal:  Oncogene       Date:  2013-03-04       Impact factor: 9.867

4.  The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.

Authors:  Hua Wang; Yue Chen; Ping Lin; Lei Li; Guisheng Zhou; Guangchao Liu; Craig Logsdon; Jianping Jin; James L Abbruzzese; Tse-Hua Tan; Huamin Wang
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

5.  The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation.

Authors:  Xinsong Xu; Antonio Sarikas; Dora C Dias-Santagata; Georgia Dolios; Pascal J Lafontant; Shih-Chong Tsai; Wuqiang Zhu; Hidehiro Nakajima; Hisako O Nakajima; Loren J Field; Rong Wang; Zhen-Qiang Pan
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

Review 6.  MicroRNA in prostate cancer.

Authors:  Kasomva Khanmi; Savarimuthu Ignacimuthu; Michael Gabriel Paulraj
Journal:  Clin Chim Acta       Date:  2015-09-28       Impact factor: 3.786

7.  Identification of mutations in CUL7 in 3-M syndrome.

Authors:  Céline Huber; Dora Dias-Santagata; Anna Glaser; James O'Sullivan; Raja Brauner; Kenneth Wu; Xinsong Xu; Kerra Pearce; Rong Wang; Maria Luisa Giovannucci Uzielli; Nathalie Dagoneau; Wassim Chemaitilly; Andrea Superti-Furga; Heloisa Dos Santos; André Mégarbané; Gilles Morin; Gabriele Gillessen-Kaesbach; Raoul Hennekam; Ineke Van der Burgt; Graeme C M Black; Peter E Clayton; Andrew Read; Martine Le Merrer; Peter J Scambler; Arnold Munnich; Zhen-Qiang Pan; Robin Winter; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

Review 8.  Pathogenic and therapeutic role of miRNAs in breast cancer.

Authors:  Vittal Venkatasatya Kurisetty; Rajkumar Lakshmanaswamy; Chendil Damodaran
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

Review 9.  Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes.

Authors:  Shawna V Hudson; Denalee M O'Malley; Suzanne M Miller
Journal:  Patient Relat Outcome Meas       Date:  2015-03-19

10.  Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function.

Authors:  Petr V Nazarov; Susanne E Reinsbach; Arnaud Muller; Nathalie Nicot; Demetra Philippidou; Laurent Vallar; Stephanie Kreis
Journal:  Nucleic Acids Res       Date:  2013-01-17       Impact factor: 16.971

View more
  2 in total

1.  Genome-wide identification and functional analysis of the WDR protein family in potato.

Authors:  Nianjiao Tao; Wenjiao Zhu; Minjie Gan; Min Chen; Ting Li; Alexander Tendu; Dongli Jiao; Man Wang; Chunmei Xue; Yuanmi Lin; Qing Yang
Journal:  3 Biotech       Date:  2019-11-01       Impact factor: 2.406

2.  Knockdown of the long non-coding RNA CACNA1G-AS1 enhances cytotoxicity and apoptosis of human diffuse large B cell lymphoma by regulating miR-3160-5p.

Authors:  Qiqi Zhou; Yan Zhang; Meiqing Zhao; Xia Zhao; Hongwei Xue; Shuxin Xiao
Journal:  Exp Ther Med       Date:  2022-08-18       Impact factor: 2.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.